BOT 1.35% 37.5¢ botanix pharmaceuticals ltd

And on top of the proven capability of Permatrex to deliver...

  1. 295 Posts.
    lightbulb Created with Sketch. 325
    And on top of the proven capability of Permatrex to deliver cannabinoids into the skin, one of the 4 treatments tested in BOT's trial - BTX1308 3 - was a whopping 20% concentration, if the conclusion of that patent application (20190060250) is legit we should get some remarkable results:

    CONCLUSION

    "[0074] These data indicate that CBG/CBD oil significantly reduces the symptoms of psoriasis. The controls receiving placebo oil did not show any improvement while CBG/CBD at higher concentration showed an improvement on psoriasis as assessed by the Psoriasis Area Severity Index. "

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.5¢
Change
0.005(1.35%)
Mkt cap ! $669.7M
Open High Low Value Volume
37.0¢ 38.0¢ 36.5¢ $740.7K 1.988M

Buyers (Bids)

No. Vol. Price($)
27 325802 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 109816 2
View Market Depth
Last trade - 13.26pm 15/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.